<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6711BFCB-ACD5-4149-9C97-283269DF2778"><gtr:id>6711BFCB-ACD5-4149-9C97-283269DF2778</gtr:id><gtr:name>Mayo Clinic</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Neurology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6711BFCB-ACD5-4149-9C97-283269DF2778"><gtr:id>6711BFCB-ACD5-4149-9C97-283269DF2778</gtr:id><gtr:name>Mayo Clinic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/73771842-1F5F-417D-B3E9-1C95161A8FA9"><gtr:id>73771842-1F5F-417D-B3E9-1C95161A8FA9</gtr:id><gtr:firstName>Nick</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Fox</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601846"><gtr:id>135E2846-046E-4AFA-8357-FD70E40C7F44</gtr:id><gtr:title>Improving Diagnosis And Measurement Of Progression In Dementia: Longitudinal Clinical And MRI Studies</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0601846</gtr:grantReference><gtr:abstractText>In the UK there are already 700,000 people with dementia and this number is set to double in the next 20 years. Alzheimer?s disease is the commonest of many causes. These diseases are difficult to diagnose at an early stage. Magnetic resonance scans provide detailed pictures of the brain. The amount and pattern of brain loss (atrophy) on the scan can help make a diagnosis. Unfortunately visual assessment is not good at distinguishing disease from age-related change; new measures are needed. I have developed methods of scanning using computers to measure changes on brain scans. I will use and improve these techniques to measure how fast brain tissue is being lost and from where. I will assess how these changes relate to clinical symptoms and cognitive decline. I will also compare atrophy measure to other markers, including scans for amyloid (a protein that accumulates in AD brains). This will help us diagnose the diseases that cause dementia and understand how they progress. Importantly these techniques are now also being used in trials to assess therapies. Ultimately I hope these methods will help identify effective treatments for these devastating conditions and enable them to be provided as early as possible through earlier improved diagnosis.</gtr:abstractText><gtr:technicalSummary>Aims/objectives
 Achieve earlier and more precise diagnosis in Alzheimer?s disease (AD) and related disorders, including pre-clinical detection of disease;
 Improve understanding of the pathophysiological evolution of neurodegenerative diseases and the relationships between imaging and clinical manifestations;
 Measure disease progression, and assess its correlates and influences; 
 Evaluate symptomatic and potentially disease-modifying therapies.
Design/methods
Measures of cerebral change will be improved by optimising MRI acquisition reproducibility and post-acquisition artefact correction. Optimised protocols and artefact correction will be developed for 3T phased array acquisitions for 3D T2-weighted as well as T1-weighted volumetric studies. Linear and non-linear registration will be used to match imaging studies across modality and over time. 
Registration-based measures of atrophy rates will be further developed - and different approaches critically compared and the topography of progression will be assessed. The precision of measures will be improved with multiple time point imaging. Registration and quantification techniques will be developed that fully incorporate multiple time point studies, fitting the time series rather than each pair of scans independently. I will determine the minimum scan-interval needed for serial MRI to a) detect and b) distinguish neurodegenerative disorders. I will pursue the potential for reduced sample sizes in trials by reducing within-subject variability in atrophy rate measures and investigating run-in designs. 
I will further develop registration-based methods for quantifying progression of regional and global atrophy and parenchymal change and for measurement of cortical thickness changes: for these aims I will investigate combined serial 3D T2-weighted and T1-weighted imaging. 

I will combine and correlate atrophy measures with CSF markers and amyloid imaging (C11-PIB- PET) to determine the topography and assiation between amyloid deposition and neuronal loss. I will also correlate imaging changes with neuropsychometry to understand the temporal and topographical association between neuronal loss, amyloid deposition and cognition.
I will apply these techniques to well-characterised clinical cohorts with established disease and also to individuals at risk of familial AD, prion, Huntington?s and fronto-temporal dementia. These cohorts offer a unique opportunity to study pre-symptomatic disease. Additionally I will study mild cognitive impairment (MCI) and subjects who have amnestic complaints but do have a sufficient memory deficit to fulfil criteria for MCI (which may represent a pre-MCI stage). 

This programme of research offers clinical as well as scientific opportunities in the dementias but should also have relevance to other disorders where precise and yet easily applicable measurements of cerebral changes are important.</gtr:technicalSummary><gtr:fund><gtr:end>2013-01-02</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1175334</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Prion Unit</gtr:department><gtr:description>Dementia Genetics and Correlates</gtr:description><gtr:id>8A158DC4-5AF5-48C1-B711-F39D5A1EB8E0</gtr:id><gtr:impact>Publications 
PMID: 20802216; PMID: 20209083; PMID: 20177119; 
PMID: 19754925; PMID: 18648346; PMID: 18413474; PMID: 16505331
Multidisciplinary - neurologists and geneticists</gtr:impact><gtr:outcomeId>51BDEBF9610-1</gtr:outcomeId><gtr:partnerContribution>Genetic Analyses Intellectual input</gtr:partnerContribution><gtr:piContribution>Data
Clinical problem and input</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Medical Image Computing</gtr:department><gtr:description>CMIC</gtr:description><gtr:id>F95BAEA1-388C-4C8E-B5EA-75EAEB3FB409</gtr:id><gtr:impact>papers
ideas for research grants
multi-disciplinary - clinicians, computer scientists, physicists</gtr:impact><gtr:outcomeId>jSAWexk3Mn2-1</gtr:outcomeId><gtr:partnerContribution>Image analysis techniques;
processing of data;
access to computer clusters
PhD students</gtr:partnerContribution><gtr:piContribution>Provision of scans and clinical expertise and clinical material</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>MRI and Biomarkers in HD</gtr:description><gtr:id>3A885688-7A52-4DE1-BBCE-626105F8F7CD</gtr:id><gtr:impact>Grants - including the TRACK HD internaional collaboration 
PhDs - Susie Henley awarded 2008 Ed Wild awarded 2009 
Publications - PMID: 20461806; PMID: 20150305; PMID: 20037137; PMID: 19955112 PMID: 19646924 PMID: 19523522 PMID: 19266143 PMID: 19243073 PMID: 18407301 PMID: 16924028
 
Multidisciplinary - neurologists, psychologists, computer scientists, physicists</gtr:impact><gtr:outcomeId>E41FF3DC9AD-1</gtr:outcomeId><gtr:partnerContribution>Data 
Clinical input 
Joint students</gtr:partnerContribution><gtr:piContribution>Provision of Software Techniques Advice and Intellectual Input Image analyses</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Washington</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Washington University</gtr:description><gtr:id>123A6EB1-49CE-43BE-941B-689106C94360</gtr:id><gtr:impact>Paper - Noted in publication section - PMID 19656505</gtr:impact><gtr:outcomeId>qvVNCzj9ons-1</gtr:outcomeId><gtr:partnerContribution>Paper - Piwnica-Worms C, et al - Cortex, 2010</gtr:partnerContribution><gtr:piContribution>patients, MRI scans, funding for patient visits to our Centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>GWAS in AD</gtr:description><gtr:id>350A4897-AAB3-43FF-874E-5D45DA50995E</gtr:id><gtr:impact>Publication PMID: 19734902 
Publicity - Listed in top ten medical advances in 2009 by Time magazine
Cited 145 times by Nov 2010 (Google scholar)
Multidisciplinary - neurologists, psychiatrists, geneticists</gtr:impact><gtr:outcomeId>F09BAAB6248-1</gtr:outcomeId><gtr:partnerContribution>Genetic analysis</gtr:partnerContribution><gtr:piContribution>Provision of data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Washington</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>DIAN</gtr:description><gtr:id>082BCA57-855F-4861-8F2D-F539FD26444A</gtr:id><gtr:impact>Presentation at scientific meetings
Papers in press
Funding (from a charitable Foundation - anonymous)</gtr:impact><gtr:outcomeId>7DE308A4EFF-1</gtr:outcomeId><gtr:partnerContribution>Ability to use data and to apply for charitable funding on the basis of these data</gtr:partnerContribution><gtr:piContribution>Data Image analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eli Lilly &amp; Company Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Amyloid imaging provision of ligand (AVID Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly)</gtr:description><gtr:id>E1B9DA06-E4AB-40E3-BD22-0F334C3BB965</gtr:id><gtr:impact>Ongoing - none yet</gtr:impact><gtr:outcomeId>gdJsGAsQK7r-1</gtr:outcomeId><gtr:partnerContribution>Provision of PET tracer for amyloid imaging and contribution to design of study</gtr:partnerContribution><gtr:piContribution>Design of study and provision of patients and conduct of study</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mayo Clinic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>ADNI</gtr:description><gtr:id>064D0317-7CB0-43B2-9F5C-E7FF40881FB8</gtr:id><gtr:impact>Publicity The ADNI - Alzheimer's Disease Neuroimaging Initiative is the largest study of its kind ($60million) and I (my group) am the only non-US member of the consortium 
ADNI has been covered in several general readership journals and papers and on the AlzForum
ADNI has been the focus of special issues in several journals
Publications include 
PMID: 20620665; PMID: 20451869; PMID: 20230901; PMID: 19760240; 
PMID: 19477282 PMID: 19437497 PMID: 19339253 PMID: 18202106 PMID: 18063391 PMID: 16480900 PMID: 19042931 PMID: 18378167</gtr:impact><gtr:outcomeId>E516E1BEB69-2</gtr:outcomeId><gtr:partnerContribution>Data Intellectual inputData Intellectual input Data processing</gtr:partnerContribution><gtr:piContribution>Helped design the study and the preparatory phase
Image Analyses 
Intellectual input</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>MRI in MS</gtr:description><gtr:id>2AFF4167-BE78-487C-81CA-0282DAB1DEC3</gtr:id><gtr:impact>Pub lications PMID: 17238871 PMID: 16596564 PMID: 17940723</gtr:impact><gtr:outcomeId>1D3EB6AB2CF-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input Data</gtr:partnerContribution><gtr:piContribution>Provision of software Training Advice and intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>ADNI</gtr:description><gtr:id>C64A7C58-785B-473E-9F21-852A1F652CC4</gtr:id><gtr:impact>Publicity The ADNI - Alzheimer's Disease Neuroimaging Initiative is the largest study of its kind ($60million) and I (my group) am the only non-US member of the consortium 
ADNI has been covered in several general readership journals and papers and on the AlzForum
ADNI has been the focus of special issues in several journals
Publications include 
PMID: 20620665; PMID: 20451869; PMID: 20230901; PMID: 19760240; 
PMID: 19477282 PMID: 19437497 PMID: 19339253 PMID: 18202106 PMID: 18063391 PMID: 16480900 PMID: 19042931 PMID: 18378167</gtr:impact><gtr:outcomeId>E516E1BEB69-1</gtr:outcomeId><gtr:partnerContribution>Data Intellectual inputData Intellectual input Data processing</gtr:partnerContribution><gtr:piContribution>Helped design the study and the preparatory phase
Image Analyses 
Intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BBC Radio 4 - interview on Women's Hour</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7275C9AD-37FC-4E17-A10E-9417B2E4E1B9</gtr:id><gtr:impact>Women's Hour has a large audience and I was interviewed to explain neuropsychological testing in the investigation of dementia

Increased awareness of neuropsychological testing 
A number of enquiries about research</gtr:impact><gtr:outcomeId>JdFux3fX9VQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Television - interview with Channel 4 News fAD</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>44404E57-1F9C-4407-AF6C-BE0832EB7975</gtr:id><gtr:impact>Primetime TV - talking about presymptomatic trials in Alzheimer's disease - resulted in increased awareness and has led to numerous enquiries and offers of help with research

Increased awareness of AD and of research</gtr:impact><gtr:outcomeId>HxXWqNRgJSE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New York Times</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7BAD8FEF-618E-4F71-9492-8BE5FF5B4CF3</gtr:id><gtr:impact>Telephone Interview to discuss the paper published in Lancet Neurology

Increased awareness of AD and of research</gtr:impact><gtr:outcomeId>H3Q9nR5u2EZ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit - Canterbury</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F3E3F9FA-F2D3-4890-A854-207C61FCE669</gtr:id><gtr:impact>The visit was a full day and included giving an assembly to the full school (over 300 students) and two separate workshops with 6th formers which sparked questions about careers in science and medicine.

At this stage, only increased interest in science and medicine. Two pupils cycled across UK to raise money for Alzheimer's disease.</gtr:impact><gtr:outcomeId>mMgMzXYApfA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Horizon - filming 2015-16</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3D362B19-38F7-4268-BECE-CBE5AE92DEC1</gtr:id><gtr:impact>BBC Horizon were interested in making a programme about Alzheimer's disease with a focus on novel technology - especially imaging - for early diagnosis and trials.
Several meetings were held with the produced and his team and then several days of on-site filming including following a research subject.
The film is due to be shown in Spring 2016 as a one hour long programme which is likely to reach an audience of more than a million</gtr:impact><gtr:outcomeId>56e04162cb7c82.67188981</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alzheimer's Society debate: How can we beat dementia in the next twenty years</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8C05D9EC-F501-40DE-A721-CEB805F9AF60</gtr:id><gtr:impact>Organised by the Alzheimer's Society. this involved patients, carers, supporters and the media who have had subsequent interest in research. very positive feedback from the Alzheimer's Society who were grateful for the input.</gtr:impact><gtr:outcomeId>58bfdc208becf7.04803794</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Schools Visit to CMIC UCL</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B4255F44-54F4-422E-9F10-EC72FB36B775</gtr:id><gtr:impact>As part of an EPSRC Science into Schools project (PI - Derek Hill) I presented my research showing how physics and science can contribute to medical research

Not evaluated formally but feedback from the school was increased interest in science</gtr:impact><gtr:outcomeId>1649F9C97B3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Academy of Arts</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A2633F4F-BABA-4075-AE39-03B7DE8F901B</gtr:id><gtr:impact>100 individuals working in the arts - museum and gallery managers
Active discussion

Request since then for further information</gtr:impact><gtr:outcomeId>ovYvoHU8oqm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Familial AD support group</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A2C899A7-2199-4B0B-B0B3-B79367477534</gtr:id><gtr:impact>40 family members and care representatives attended and asked questions and were interested in helping with research

willingness to help with a web site and with an information video</gtr:impact><gtr:outcomeId>TmGT8b9kUMs</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio 4 interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FF3119A2-FD75-4FDF-80D1-DDB9E51F6A25</gtr:id><gtr:impact>Radio 4 audience

Unclear</gtr:impact><gtr:outcomeId>ish8sMTvoWm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Web-based series of articles</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DB249CC7-954C-4F15-B0E5-BFCB00CAFFC9</gtr:id><gtr:impact>Interviewed on my research on the ARF website as part of a series on Familial AD

Increased awareness - this is very frequently accessed site and newsletter</gtr:impact><gtr:outcomeId>9F3BE372E77</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Many Faces of Dementia - massive open online course (MOOC)</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A0F87F21-1A8E-4D8E-9F88-77D81FE66F17</gtr:id><gtr:impact>I was interviewed for an online course about the rarer forms of dementia, my interview related to the clinical features of frontotemporal dementia. I also performed the voice over and welcome to the course that appeared in the course trailer video. The course, due to start March 14th 2016 is a 'massive open online course' available at www.futurelearn.com/courses/faces-of-dementia. Over 12,000 people have registered for the course (as of 8th March 2016).</gtr:impact><gtr:outcomeId>56dee25b908d37.28200715</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.futurelearn.com/courses/faces-of-dementia</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Rare Dementia Support Group Launch 2016</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CCF3EA73-DDAA-41BD-BE35-D149C59398E1</gtr:id><gtr:impact>Rare Dementia Support Fund created with the ambition to increase fundraising and extend the support service further, throughout the UK and beyond.
Extremely well attended</gtr:impact><gtr:outcomeId>56dedb53e93117.65300017</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.nationalbrainappeal.org/rare-dementia-support-launch-event/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio 4 - (All in the mind) Interview 2012</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>878FB282-629D-4FB7-B1C6-591D56DC5B83</gtr:id><gtr:impact>Programme called &amp;quot;All in the Mind&amp;quot; - a series which will be broadcast at the end of October 2012 - this particular session was about presymptomatic treatment for Alzheimer's

Increased awareness of AD and of research
A number of individuals contacted the department offering to take part in research</gtr:impact><gtr:outcomeId>N3LN91WFKUf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UCL Lunch Hour Lectures</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0A581A6D-2BB4-4FC8-884E-444AB32393A9</gtr:id><gtr:impact>This series of lectures are UCL's opportuity to engage with public audiences (anyone can come to the lectures and they are free). The lecture each week is streamed live online which reaches a larger audience.
Date: 15th November, 2012
Location: UCL campus - Darwin Lecture Theatre
Title: Presymptomatic treatment for AD: feasible or fanciful?

Too early to say.</gtr:impact><gtr:outcomeId>Hmc2Q3KRKRC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Young Onset and Rare Dementias 2014 event at House of Lords</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8C423A95-31F4-4EF8-BB82-3E8BB791524D</gtr:id><gtr:impact>Awareness-raising event regarding young onset and rare dementias
The event was attending by member of parliament and the House of Lords as well as charities, patient families and other organisations</gtr:impact><gtr:outcomeId>56dedbf875e258.04358196</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>https://www.youngdementiauk.org/news/young-onset-awareness-event-house-lords</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Television programme</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B1E0AEA6-2619-48E5-941F-249F0C00AC53</gtr:id><gtr:impact>Spoke on famililal Alzheimer's disease

Member of the public contacted the department for details of research</gtr:impact><gtr:outcomeId>ctmxxBwecAU</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview - BBC radio 4</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DAEB47A4-AFFD-4BB1-92CF-DF09C7979BB5</gtr:id><gtr:impact>Interviewed by the BBC Radio following a press release by the ARUK in September

Increased awareness of AD and of research</gtr:impact><gtr:outcomeId>pd7p83KnPnB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PCA Support Group</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>45932E1B-41DB-4F0E-ABB5-B30CB6EEB287</gtr:id><gtr:impact>Presented research

Participation in research</gtr:impact><gtr:outcomeId>3C15C2C380B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press briefing - related to Howard et al NEJM</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>336654F5-2E82-4465-BAFC-FFBEED35E5CA</gtr:id><gtr:impact>A large number of print and other media representatives covered the story

Increased awareness</gtr:impact><gtr:outcomeId>tcD1ALpXYvX</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio and TV - Lancet Neurology commentary</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>81BB2C3B-6E09-4B17-9EDB-BD8F75F61543</gtr:id><gtr:impact>I was asked to provide a commentary on a paper published in Lancet Neurology

Numerous media responses followed by requests to appear on radio and TV explaining to the layperson, the possible implications of the above paper (Reiman et al)</gtr:impact><gtr:outcomeId>rq9p6D5fvmW</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pick's Disease Support Group</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>68DE6481-6ABD-480D-8A31-AD0BB969A783</gtr:id><gtr:impact>Explained my research to groups of patients and carers

Research participation</gtr:impact><gtr:outcomeId>C3FB67734C9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC World Television - interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>706D1320-0237-4660-831F-5E16A050A642</gtr:id><gtr:impact>Asked to comment on the paper published by Lancet Neurology on 2nd November - I had provided a &amp;quot;commentary&amp;quot; on the paper which was also published in Lancet Neurology

Increased awareness of AD and of research</gtr:impact><gtr:outcomeId>ZPxbUxQkx7f</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C4A34F04-5900-41AE-883E-0E175E1E1D33</gtr:id><gtr:impact>Talk led to a lot of questions and discussion - for almost an hour after the event

A number of people expressed interest in taking part in research</gtr:impact><gtr:outcomeId>5648c804c46907.04699825</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/event/cheltenham-science-festival/</gtr:url><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interviews and material for Alz Soc web site</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6466DF9D-8A3D-493B-B901-F78725657946</gtr:id><gtr:impact>I have been interviewed for the web sites of the Alzheimer's Society and Alzheimer's Research UK - these sites are very frequently accessed
I have provided material - images and text for both websites

Increased awareness</gtr:impact><gtr:outcomeId>Befg1Lj4pUB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medicine and Me:  Living well with Dementia</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FF54149D-99A6-43C8-A433-D2172F5B5526</gtr:id><gtr:impact>Giving a talk on types and diagnosis of dementia at this half day meeting.

The Medicine and Me series of meetings at the RSM aim to update on important conditions and gives a direct voice to patients and their carers to air their concerns on the impact of diagnosis, investigation and management. Physicians and surgeons and indeed all healthcare professionals continue to learn from and be inspired to greater efforts by our patients to improve care.
The audience at this meeting will comprise of those living with dementia, their families, carers and advocates, representing about 70% of those present; and clinicians and researchers, representing not more than 30%. Clinicians will include doctors, specialist nurses and others involved in the treatment and care of those who have this condition</gtr:impact><gtr:outcomeId>56e12b3ccd1859.38038793</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.rsm.ac.uk/events/events-listing/2015-2016/groups/public-engagement-programme/mmg01-medicine-and-me-living-well-with-dementia.aspx</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio - Science Reporting</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>80C7FB75-3DCE-4EA5-8065-9822E0F6F5A1</gtr:id><gtr:impact>Asked to discuss the findings of the publication in Lancet Neurology (published on 2nd November).

Increased awareness of AD and of research</gtr:impact><gtr:outcomeId>UdedQepDZDG</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1430544</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme grant</gtr:description><gtr:end>2014-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8E2FC6EA-97D1-448B-A153-1C09A6430DCF</gtr:id><gtr:outcomeId>as2ARfm3Z7U0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>343000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Anonymous (peer reviewed)/Charitable Foundation (Anonymous)</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Fidelity Biosciences</gtr:fundingOrg><gtr:id>9696AC62-821F-4935-A881-70C1F76E92FB</gtr:id><gtr:outcomeId>84D1279B4220</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ART co-operative grant</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>511E1F0B-9E8C-4827-916F-33BB87858F54</gtr:id><gtr:outcomeId>iqvFmVJfB2P0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>174791</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Bloomsbury Centre</gtr:department><gtr:description>Wellcome Trust Clinical Research Training Fellowship</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>4B838C60-D1A3-4287-8C09-612B6E562285</gtr:id><gtr:outcomeId>583da24675cda8.45058784</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Young onset dementia</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ARUK-network2012-6-ICE</gtr:fundingRef><gtr:id>2F84ADCD-7D93-48D3-AE4A-8EA242210030</gtr:id><gtr:outcomeId>PdEmaCw78MW</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1069569</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Europond - European Progression of Neurodegenerative Disease Initiative</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>H2020-PHC-2014-2015-666992</gtr:fundingRef><gtr:id>6F789CD1-AE49-4304-86E8-D54046FF1F45</gtr:id><gtr:outcomeId>583d57c4462a45.12379790</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>278516</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>TSB Competitive Industrial Partnership</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Technology Strategy Board (TSB)</gtr:fundingOrg><gtr:id>4B46DE20-BE66-45FD-84D5-75C6C1B8EB82</gtr:id><gtr:outcomeId>42791A823FE0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>167991</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GENFI</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>4AA4086E-59D2-4DCF-B751-DFC411D158E6</gtr:id><gtr:outcomeId>Yj7AHfCGyS40</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99995</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alzheimer's Society, Whole Genome Sequencing in patients and families with dementia</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Alzheimer?s Society</gtr:fundingOrg><gtr:fundingRef>263 AS-PG-15-037</gtr:fundingRef><gtr:id>EEDD7424-8E26-4526-B890-321682AC660A</gtr:id><gtr:outcomeId>5834612c7fd479.59997632</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wolfson Foundation Award to UCL for Experimental Neurology Centre</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>The Wolfson Foundation</gtr:fundingOrg><gtr:id>3F62B477-C285-4AA8-814A-BCA668F8A61F</gtr:id><gtr:outcomeId>Cs9kQFNKLCz</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2614282</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Dementia Biomedical Research Unit</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>4F0DF611-84B1-42C2-A9C9-91B29FA35C82</gtr:id><gtr:outcomeId>UPNEwTzEsLM</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Manja Lehmann Alzheimer's Society PhD Studentship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Alzheimer?s Society</gtr:fundingOrg><gtr:id>06A9F397-1F4E-429A-BAF8-2AFBE8E12A90</gtr:id><gtr:outcomeId>FC4DB9794CD0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Equipment Grant</gtr:description><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>31668369-CB4B-4896-897A-897676A10539</gtr:id><gtr:outcomeId>bqyw2xQkrMP0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60852</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Drake Foundation: Effects of head injury the NSHD 1946 birth cohort.</gtr:description><gtr:end>2019-04-02</gtr:end><gtr:fundingOrg>The Drake Foundation</gtr:fundingOrg><gtr:id>A3731630-7D1B-4D26-B50C-BA3D585702F6</gtr:id><gtr:outcomeId>58bfc9c7651032.87324700</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>153830</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ART Non-clinical fellowship</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>38E93602-480E-400A-97B1-8D3CC166B981</gtr:id><gtr:outcomeId>F9E8CEC5E2C0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1824093</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>1946 ARUK</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ARUK-PG2014-1946</gtr:fundingRef><gtr:id>6401195A-CF8E-45E7-B6F5-4B06F119C911</gtr:id><gtr:outcomeId>5463ded1290699.41202098</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>An automated methjod of checking the quality of scans and that they have been done to the required protocol</gtr:description><gtr:grantRef>G0601846</gtr:grantRef><gtr:id>5904389F-FB7E-42C8-B5D6-FA424DCCFC1A</gtr:id><gtr:impact>No notable impact</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>Mg3Ev1cFJo9</gtr:outcomeId><gtr:patentId>WO2008135740</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>QA Box</gtr:title><gtr:yearProtectionGranted>2008</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Method for analysing MRI scans for atrophy</gtr:description><gtr:grantRef>G0601846</gtr:grantRef><gtr:id>EAFB753D-5235-4D29-96A6-75D6B66D2791</gtr:id><gtr:impact>Papers and commercial contracts</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>GrR2RckKQty</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>Boundary Shift Integral (BSI)</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>software designed to compare brain atrophy from scans provided by research patients - The standard reference for MIDAS is:

Freeborough PA, Fox NC, Kitney RI. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Computer Methods and Programs in Biomedicine 1997; 53: 15-25</gtr:description><gtr:grantRef>G0601846</gtr:grantRef><gtr:id>A581CB30-DF7E-4E4E-B51B-AEA113A34853</gtr:id><gtr:impact>Huge impact on all clinical trials conducted by my department since MIDAS was introduced</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>o7TMKH8N3iA</gtr:outcomeId><gtr:protection>Copyrighted (e.g. software)</gtr:protection><gtr:title>MIDAS</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>FTLD international criteria</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E367C21F-7FFC-4B55-AD75-5E9A1B22C346</gtr:id><gtr:impact>Contributed to formulation of international criteria for diagnosis of frontotemporal dementia</gtr:impact><gtr:outcomeId>BEnc7r3xTtM</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NIA-AA New Criteria for Alzheimer's disease and MCI</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9AB341F7-685D-4393-851E-95ED94ED51F3</gtr:id><gtr:impact>I was part of a small guideline committee to update the consensus guidelines for Alzheimer's disease. I shared leadership of the biomarker section in the new criteria. This is a major change in the way Alzheimer's disease will be diagnosed incorporating biomarkers for the first time.</gtr:impact><gtr:outcomeId>rhUhfh7Aaj7</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Hosted 1/2 day visit by Secretary of State for Health Jeremy Hunt Nov 2013</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C2A35E69-A59C-4383-A8B5-89B98B34458B</gtr:id><gtr:outcomeId>56e04a64106ff3.84464849</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type><gtr:url>https://www.ucl.ac.uk/news/news-articles/1213/111213-leading-world-dementia-ucl</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EMA opinion on use of hippocampal volumes in trials 2011-12</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>1F62D3E2-41B3-4E26-B6A0-54E4596476E9</gtr:id><gtr:impact>The guidance supports the use of MRI based measures for trial inclusion - this should make trials more efficient</gtr:impact><gtr:outcomeId>56e04ce49910f0.97790616</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2011/10/WC500116264.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>PCA criteria 2013-2015</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>63CA9E8B-9E51-43EA-AC49-BAE27F14AC46</gtr:id><gtr:outcomeId>56e04b7c10cba2.49226150</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://www.alzforum.org/news/conference-coverage/researchers-join-draw-posterior-cortical-atrophy-out-shadows</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the Prime Minister's Research Champions Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>44D66A58-9C67-4DDC-BEDD-C918CB5586A8</gtr:id><gtr:outcomeId>rE7mKcHTaK3</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>PM's Dementia Challenge</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B156D20B-5BA3-43EE-9528-43ABB73D242A</gtr:id><gtr:outcomeId>r1MYaVMSHnp</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>This is a new imaging biomarker which at this stage is being developed for use in clinical trials as an outcome measure. It may be of value clinically with further development.</gtr:description><gtr:id>84692D4C-2823-44A3-B416-B8E3DA6CEFB6</gtr:id><gtr:impact>The automated hippocampal measure has been adopted for use in a multi centre clinical trial as part of an image analysis contract.</gtr:impact><gtr:outcomeId>kdDkcVjuDeR</gtr:outcomeId><gtr:stage>Small-scale adoption</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Automated hippocampal measures from MRI</gtr:title><gtr:type>Support Tool - For Medical Intervention</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>An improved method for measuring rates of brain atrophy</gtr:description><gtr:id>8BAE94A1-4B46-4487-B6A1-33CEFE621D9F</gtr:id><gtr:impact>Adopted in a number (&amp;gt;20 since 1996) of international clinical trials</gtr:impact><gtr:outcomeId>425ADDD8A82</gtr:outcomeId><gtr:stage>Small-scale adoption</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Boundary Shift Integral</gtr:title><gtr:type>Diagnostic Tool - Imaging</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>We provided the serial imaging from AD and Control research subjects acquired as part of the Minimal Interval Resonance Imaging in Alzheimer's Disease (MIRIAD) Study

The MIRIAD dataset is a database of volumetric MRI brain-scans of 46 Alzheimer's sufferers and 23 healthy elderly people. Many scans were collected of each participant at intervals from 2 weeks to 2 years and includes 708 scans.</gtr:description><gtr:id>667DCC3F-BF02-40DD-9ED6-125AA7C98075</gtr:id><gtr:impact>The database has been used for a MICCAI challenge</gtr:impact><gtr:outcomeId>56e05d3da4c2b2.58980934</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MIRIAD Scan Public Database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/23274184</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Longitudinal series of MRI scans in AD and controls with associated anonymised clinical material</gtr:description><gtr:id>0DE50E91-C70F-426B-B4A6-3C52FEC0BA5F</gtr:id><gtr:impact>A conference presentation where seven international groups analysed the datasets and a paper is planned</gtr:impact><gtr:outcomeId>cSqmgZRteAr</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MIRIAD</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Publically available pre-processed MR scans of subjects with AD (n=200); MCI (n=400) and normal elderly (n=200). Also provided analyses - brain volumes and rates of atrophy - freely available.</gtr:description><gtr:id>932C0CFE-79A3-4C10-AD71-EA9A7458AED4</gtr:id><gtr:impact>Numerous publications (see ADNI) - the data may contribute to more efficient clinical trials in AD</gtr:impact><gtr:outcomeId>CD226046481</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MRI scans in ADNI database</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>New technique for analysing VBM</gtr:description><gtr:id>DA601366-9DAD-4572-9135-95D9CEDCBE6C</gtr:id><gtr:impact>Cited journal article 
Ridgway et al Neuroimage</gtr:impact><gtr:outcomeId>LrQ1vGkMUsK</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>VBM masking</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>IXICO</gtr:companyName><gtr:description>www.ixico.co.uk 
Image analysis service provider</gtr:description><gtr:id>79902688-2C5F-4F4F-8B9A-F9A8D07AC385</gtr:id><gtr:impact>led to large contracts being awarded</gtr:impact><gtr:outcomeId>BNPZSdZ1Mzo</gtr:outcomeId><gtr:url>http://www.ixico.co.uk</gtr:url><gtr:yearCompanyFormed>2006</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>E6056BA2-F311-487F-9FBD-4EA83C8724F7</gtr:id><gtr:title>Presymptomatic studies in genetic frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Revue neurologique</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0035-3787</gtr:issn><gtr:outcomeId>pm_14403_23_24012408</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEF539FE-D801-4E7B-9058-C64EBF0039E2</gtr:id><gtr:title>Delusions in frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/789510c93298cb4bd3f287a5612764c3"><gtr:id>789510c93298cb4bd3f287a5612764c3</gtr:id><gtr:otherNames>Omar R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>M57U82FN4Ef</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>975D6126-C852-4B23-9971-DE0A24327EA6</gtr:id><gtr:title>Automatic classification of MR scans in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0db57caf0730d369d7172f0f5c17a375"><gtr:id>0db57caf0730d369d7172f0f5c17a375</gtr:id><gtr:otherNames>Kl?ppel S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>850ED6786AF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C815743A-25CC-4892-907B-519BF5ED88CE</gtr:id><gtr:title>Patterns of cortical thickness according to APOE genotype in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Dementia and geriatric cognitive disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54a904c9db863eb048bca172a91b8996"><gtr:id>54a904c9db863eb048bca172a91b8996</gtr:id><gtr:otherNames>Guti?rrez-Galve L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1420-8008</gtr:issn><gtr:outcomeId>2C1B7160822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE96CAEC-3516-4E05-8A3B-FC39BE882474</gtr:id><gtr:title>Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6d4944da6060d033e7b78eb9c8749e1"><gtr:id>a6d4944da6060d033e7b78eb9c8749e1</gtr:id><gtr:otherNames>Wardlaw JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_14403_23_23867200</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7A76DBA-B742-48A9-8255-7E9278898F4F</gtr:id><gtr:title>Structural imaging markers for therapeutic trials in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>The journal of nutrition, health &amp; aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83020163299cc994d00571299cd55717"><gtr:id>83020163299cc994d00571299cd55717</gtr:id><gtr:otherNames>Fox NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1279-7707</gtr:issn><gtr:outcomeId>AA5356F4E2F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>588F9265-5460-4346-B51D-5E528244B0BB</gtr:id><gtr:title>Patterns of longitudinal brain atrophy in the logopenic variant of primary progressive aphasia.</gtr:title><gtr:parentPublicationTitle>Brain and language</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0093-934X</gtr:issn><gtr:outcomeId>pm_14403_23_23395096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50930192-EDDB-4D6F-9C6B-A20A5FA408DC</gtr:id><gtr:title>Subregional neuroanatomical change as a biomarker for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/790edf10f647b73dc8a432c59c947096"><gtr:id>790edf10f647b73dc8a432c59c947096</gtr:id><gtr:otherNames>Holland D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>D0A339D1686</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C12A0D2-968B-443A-83CC-AE965468E494</gtr:id><gtr:title>Brain imaging in Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa4f6b0417596fc8d88883270d0d8c2c"><gtr:id>aa4f6b0417596fc8d88883270d0d8c2c</gtr:id><gtr:otherNames>Johnson KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>pm_14403_23_22474610</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42D82736-DAD3-41B4-B550-CDDD15891E77</gtr:id><gtr:title>Brain-water diffusion coefficients reflect the severity of inherited prion disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2df16c0b13c37700a2c612d047aa21f4"><gtr:id>2df16c0b13c37700a2c612d047aa21f4</gtr:id><gtr:otherNames>Hyare H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>Fjha2B4XQpu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3893CEDA-C1E9-45F1-94D4-70742030DAA2</gtr:id><gtr:title>Clinical application of measurement of hippocampal atrophy in degenerative dementias.</gtr:title><gtr:parentPublicationTitle>Hippocampus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c3aed68c9625297800eab8ea5b4792"><gtr:id>69c3aed68c9625297800eab8ea5b4792</gtr:id><gtr:otherNames>Barnes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1050-9631</gtr:issn><gtr:outcomeId>6D0B3848D7C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2A248B8-0DA0-4B4B-88C8-80E0A448AAF6</gtr:id><gtr:title>Revising the definition of Alzheimer's disease: a new lexicon.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32b846982b3a25f88bcba72e5babf7c7"><gtr:id>32b846982b3a25f88bcba72e5babf7c7</gtr:id><gtr:otherNames>Dubois B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>N2faT3bZBrE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED187AD5-BDD4-4340-A1F8-7877AC91F957</gtr:id><gtr:title>Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a9c2586c68901d5c8cc3129e94e33d"><gtr:id>29a9c2586c68901d5c8cc3129e94e33d</gtr:id><gtr:otherNames>Schott JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56df3e0e1cb927.58799924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51B3E3A6-3964-4BAB-842A-0BA57C9DBC57</gtr:id><gtr:title>Exome sequencing reveals a novel partial deletion in the progranulin gene causing primary progressive aphasia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_14403_23_23904625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EADFFD97-1ED1-4707-A697-CFE568A32530</gtr:id><gtr:title>Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40e53561e2b3385a34842c6ebd022b3b"><gtr:id>40e53561e2b3385a34842c6ebd022b3b</gtr:id><gtr:otherNames>Leung KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>FaDw6NmqXYi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DA38E8B-F739-472B-AD88-CABA847B05BD</gtr:id><gtr:title>Neuropsychological correlates of whole brain atrophy in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neuropsychologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a9c2586c68901d5c8cc3129e94e33d"><gtr:id>29a9c2586c68901d5c8cc3129e94e33d</gtr:id><gtr:otherNames>Schott JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3932</gtr:issn><gtr:outcomeId>1A7A27DE5A3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C72551C-CD3C-48AD-B539-138F92EC2F86</gtr:id><gtr:title>Gray matter atrophy rate as a marker of disease progression in AD.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f3130ea4a1e2d25c6621789ef091e57"><gtr:id>6f3130ea4a1e2d25c6621789ef091e57</gtr:id><gtr:otherNames>Anderson VM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>doi_55f9769761ece3ea</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A09F1E5-BAAF-4E33-82A6-95218006B54A</gtr:id><gtr:title>Atrophy patterns in Alzheimer's disease and semantic dementia: a comparison of FreeSurfer and manual volumetric measurements.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4f7c18861e0038910c2956da676a621"><gtr:id>d4f7c18861e0038910c2956da676a621</gtr:id><gtr:otherNames>Lehmann M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>hcAEoJFcc7n</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A730336-D289-443C-818D-8E32F2960914</gtr:id><gtr:title>Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fadb846c4bf0f743bd514b4d59eb4741"><gtr:id>fadb846c4bf0f743bd514b4d59eb4741</gtr:id><gtr:otherNames>Massey LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_14403_23_22488922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>837F200D-3339-4309-94CC-9758BA8CE4BE</gtr:id><gtr:title>Consistent multi-time-point brain atrophy estimation from the boundary shift integral.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40e53561e2b3385a34842c6ebd022b3b"><gtr:id>40e53561e2b3385a34842c6ebd022b3b</gtr:id><gtr:otherNames>Leung KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_14403_23_22056457</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEFD0058-9DEF-493A-BE28-404A025E7D4C</gtr:id><gtr:title>Comparison of phantom and registration scaling corrections using the ADNI cohort.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a3e9b877e08fcfa7a2c57c11a169ae7"><gtr:id>1a3e9b877e08fcfa7a2c57c11a169ae7</gtr:id><gtr:otherNames>Clarkson MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>F1D708005F9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6621944D-7305-4E48-9425-30E87BBFD45E</gtr:id><gtr:title>HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q.</gtr:title><gtr:parentPublicationTitle>BMC medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed3a8442858c25b62567496b0f208ac"><gtr:id>aed3a8442858c25b62567496b0f208ac</gtr:id><gtr:otherNames>Lloyd SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2350</gtr:issn><gtr:outcomeId>D4E5062D15B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D12EA90F-C7E8-49D8-8749-5BD1A4C9AE48</gtr:id><gtr:title>Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61702583ef39986bd78a7590de9f6e32"><gtr:id>61702583ef39986bd78a7590de9f6e32</gtr:id><gtr:otherNames>Sluimer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>AC4616EA513</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC5C991C-A0D0-42F1-B1DD-B9E481645BF8</gtr:id><gtr:title>Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0db57caf0730d369d7172f0f5c17a375"><gtr:id>0db57caf0730d369d7172f0f5c17a375</gtr:id><gtr:otherNames>Kl?ppel S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>E5399AFF0FF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>183326FC-8D92-4EC4-A2BA-CBAB173DE772</gtr:id><gtr:title>A comparison of voxel and surface based cortical thickness estimation methods.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a3e9b877e08fcfa7a2c57c11a169ae7"><gtr:id>1a3e9b877e08fcfa7a2c57c11a169ae7</gtr:id><gtr:otherNames>Clarkson MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_14403_23_21640841</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8639E3D6-1A57-479C-8663-752CF502F2DB</gtr:id><gtr:title>Imaging markers for Alzheimer disease: which vs how.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0693a531bd90c9e2d3a868ffc53529f2"><gtr:id>0693a531bd90c9e2d3a868ffc53529f2</gtr:id><gtr:otherNames>Frisoni GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_14403_23_23897875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7C0EB25-92E8-44A8-879C-521C56E77D21</gtr:id><gtr:title>Increased hippocampal atrophy rates in AD over 6 months using serial MR imaging.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c3aed68c9625297800eab8ea5b4792"><gtr:id>69c3aed68c9625297800eab8ea5b4792</gtr:id><gtr:otherNames>Barnes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>276459B3708</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9739BBE6-6ECF-475D-B4EB-BC9AABC608D5</gtr:id><gtr:title>Biomarkers for Alzheimer's disease therapeutic trials.</gtr:title><gtr:parentPublicationTitle>Progress in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62dd352243d69eac75146be22c5ef7bc"><gtr:id>62dd352243d69eac75146be22c5ef7bc</gtr:id><gtr:otherNames>Hampel H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0301-0082</gtr:issn><gtr:outcomeId>56df3e0bb7c8b5.39563402</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A0BC14B-FFEC-48E8-BC70-E14109392710</gtr:id><gtr:title>The cultural context of visual hallucinations.</gtr:title><gtr:parentPublicationTitle>Postgraduate medical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b121c4c0c64cd8e2e7e65f5c4be9911"><gtr:id>0b121c4c0c64cd8e2e7e65f5c4be9911</gtr:id><gtr:otherNames>Knight WD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0032-5473</gtr:issn><gtr:outcomeId>FFCCC686E64</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34DA13AD-98D0-402D-9D8A-AECBE28C35E6</gtr:id><gtr:title>Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ffb506e356c34ad2b5c0b070f1ae6f4"><gtr:id>9ffb506e356c34ad2b5c0b070f1ae6f4</gtr:id><gtr:otherNames>Tabrizi SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>19789EED27F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B213C801-687B-45C2-939C-5B9EC72A4ACF</gtr:id><gtr:title>Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33f6d1286765f98e3d1c0e7c6e23f4c5"><gtr:id>33f6d1286765f98e3d1c0e7c6e23f4c5</gtr:id><gtr:otherNames>Cash DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5648c9c2a3de86.97805295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40D95566-3ACD-4176-B421-397993093ED2</gtr:id><gtr:title>Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b5327600fac0a638eaadd910fc3aca7"><gtr:id>8b5327600fac0a638eaadd910fc3aca7</gtr:id><gtr:otherNames>Jack CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>4A9C51094D8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55DADB20-B01D-481F-9E2E-850ACF555B8E</gtr:id><gtr:title>Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>C2C2FFD8C6E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>345D068E-2EB2-4CAC-8D38-C8B8D624AC2D</gtr:id><gtr:title>A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>44FD8828B4A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9626F997-2670-428C-B07A-0D34C8123C9D</gtr:id><gtr:title>Rates of hemispheric and lobar atrophy in the language variants of frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm_14403_23_22406442</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C39387C7-A112-45C3-922F-36FFCA527364</gtr:id><gtr:title>Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Alzheimer's research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b563b78623bb94ca0d20ecd88c28c37"><gtr:id>0b563b78623bb94ca0d20ecd88c28c37</gtr:id><gtr:otherNames>Bateman RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>56df3e0c12dce6.37463070</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E350C37-45FC-4584-9A42-2F80B2AA10BD</gtr:id><gtr:title>Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>pNVT3szCpXr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B97384F-AACA-4223-B9E2-71D01E774C1D</gtr:id><gtr:title>Issues with threshold masking in voxel-based morphometry of atrophied brains.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cab53386592ee6a55a622a3691128c13"><gtr:id>cab53386592ee6a55a622a3691128c13</gtr:id><gtr:otherNames>Ridgway GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>AS6yW6bmiHD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7691134-3681-4E0D-9265-022D50F30F57</gtr:id><gtr:title>Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b52384d0266bc60ddab21c962b93cc25"><gtr:id>b52384d0266bc60ddab21c962b93cc25</gtr:id><gtr:otherNames>Hollingworth P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56df3e0b053b91.53924949</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBC39EEA-B9E3-4980-943E-8B4DEB73857B</gtr:id><gtr:title>Rate and acceleration of whole-brain atrophy in premanifest and early Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2ad55e1a2ad1526b8ced1a4945eda9d"><gtr:id>c2ad55e1a2ad1526b8ced1a4945eda9d</gtr:id><gtr:otherNames>Wild EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>tFGqrGfnF8q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A254C451-76A0-4333-8876-198C0928EBCF</gtr:id><gtr:title>A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3ab405150e2089e42f3d42e7d67f33a"><gtr:id>b3ab405150e2089e42f3d42e7d67f33a</gtr:id><gtr:otherNames>Lashley T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56df3e0cd19e41.41333081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>059192B4-37F7-4857-8B4E-4EE5147328FE</gtr:id><gtr:title>Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: sample size estimates.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f3130ea4a1e2d25c6621789ef091e57"><gtr:id>6f3130ea4a1e2d25c6621789ef091e57</gtr:id><gtr:otherNames>Anderson VM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>FDA3A0F3063</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4ED8421B-B2FF-4FCE-9373-0F717F82B2A4</gtr:id><gtr:title>Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid A?1-42.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a9c2586c68901d5c8cc3129e94e33d"><gtr:id>29a9c2586c68901d5c8cc3129e94e33d</gtr:id><gtr:otherNames>Schott JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>BNSC1BfWn27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83A10C25-F6A9-49F2-A494-240891E30CEC</gtr:id><gtr:title>A meta-analysis of hippocampal atrophy rates in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c3aed68c9625297800eab8ea5b4792"><gtr:id>69c3aed68c9625297800eab8ea5b4792</gtr:id><gtr:otherNames>Barnes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>86131F26781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6F51DF8-D494-4658-8008-0E55BAD03AD1</gtr:id><gtr:title>Non-verbal sound processing in the primary progressive aphasias.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e5dbab70a603e7b9ff17d91f6bcc720"><gtr:id>2e5dbab70a603e7b9ff17d91f6bcc720</gtr:id><gtr:otherNames>Goll JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>psPmj1YUH1T</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>147C4B4E-DC72-4C3E-8FFD-FC1C723331FC</gtr:id><gtr:title>Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2f8dfe154301fda0ca7dc5fa167fe8"><gtr:id>9b2f8dfe154301fda0ca7dc5fa167fe8</gtr:id><gtr:otherNames>Ryan NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>doi_55f985985bb35000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FDABA9E-BB0C-4933-96AE-D250BF9DE4F5</gtr:id><gtr:title>Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>FWkh6ovmSGj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C69D9E97-7625-43C0-B874-FDBB3F5F263D</gtr:id><gtr:title>Fully automatic hippocampus segmentation and classification in Alzheimer's disease and mild cognitive impairment applied on data from ADNI.</gtr:title><gtr:parentPublicationTitle>Hippocampus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1488b488ccd6a995ee7b4ab9ef7959d3"><gtr:id>1488b488ccd6a995ee7b4ab9ef7959d3</gtr:id><gtr:otherNames>Chupin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1050-9631</gtr:issn><gtr:outcomeId>2FC062140D0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>343FB0BC-95A5-480F-B669-376CF142C4F0</gtr:id><gtr:title>Improved maximum a posteriori cortical segmentation by iterative relaxation of priors.</gtr:title><gtr:parentPublicationTitle>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf214a08f70dd705690d3294a5e05052"><gtr:id>bf214a08f70dd705690d3294a5e05052</gtr:id><gtr:otherNames>Cardoso MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>pm_14403_23_20426142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EF232C9-B566-4BDE-BF00-0652224AC1D3</gtr:id><gtr:title>The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cb8a78e67b2350728fe64236392c6db"><gtr:id>5cb8a78e67b2350728fe64236392c6db</gtr:id><gtr:otherNames>Hobbs NZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56df3e0d3e37e7.03522922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA522BB1-2603-4473-B2F3-180867416515</gtr:id><gtr:title>Familial Alzheimer's disease and inherited prion disease in the UK are poorly ascertained.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abc3f233f373ed02719f6b6d5e5fa937"><gtr:id>abc3f233f373ed02719f6b6d5e5fa937</gtr:id><gtr:otherNames>Stevens JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56df3e0a9a8cc0.47965350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04630332-754E-4FCF-A7D8-33210EC94CAD</gtr:id><gtr:title>Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_14403_23_23434116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F766D9F4-CBBE-4A35-A630-29D1C54CFC1F</gtr:id><gtr:title>Progranulin-associated primary progressive aphasia: a distinct phenotype?</gtr:title><gtr:parentPublicationTitle>Neuropsychologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3932</gtr:issn><gtr:outcomeId>gHEXDwKDhRH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6235497B-DC22-480D-9D3F-0C7A178D6218</gtr:id><gtr:title>Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/028989dcafa83dba91c03e918dc57a1d"><gtr:id>028989dcafa83dba91c03e918dc57a1d</gtr:id><gtr:otherNames>Mahoney CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_14403_23_22366791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABD0B7E5-83BE-458D-BDDA-2B547703912E</gtr:id><gtr:title>Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40e53561e2b3385a34842c6ebd022b3b"><gtr:id>40e53561e2b3385a34842c6ebd022b3b</gtr:id><gtr:otherNames>Leung KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_14403_23_23303849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB2C3C9C-66BE-43BF-8D80-B9FFC0B7CBD9</gtr:id><gtr:title>Optimizing the design of clinical trials where the outcome is a rate. Can estimating a baseline rate in a run-in period increase efficiency?</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a572d27f190b1e731841113c55c6fab"><gtr:id>9a572d27f190b1e731841113c55c6fab</gtr:id><gtr:otherNames>Frost C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>4F431246DF6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A70F3EB-BEE4-44C8-B1C3-6F06E6EC69A2</gtr:id><gtr:title>Imaging the onset and progression of Alzheimer's disease: implications for prevention trials.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96925e58fc50223a95dd6d10f9850bc0"><gtr:id>96925e58fc50223a95dd6d10f9850bc0</gtr:id><gtr:otherNames>Liang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm_14403_23_22647263</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52100255-9E6A-4F17-879D-CF629DCAF0E1</gtr:id><gtr:title>Global gray matter changes in posterior cortical atrophy: a serial imaging study.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4f7c18861e0038910c2956da676a621"><gtr:id>d4f7c18861e0038910c2956da676a621</gtr:id><gtr:otherNames>Lehmann M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>pm_14403_23_22365384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C84251B4-073E-4EDA-B821-EB38241AC4C6</gtr:id><gtr:title>A novel A781V mutation in the CSF1R gene causes hereditary diffuse leucoencephalopathy with axonal spheroids.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bab3900531f14960d7de22aaa9753c9"><gtr:id>4bab3900531f14960d7de22aaa9753c9</gtr:id><gtr:otherNames>Ahmed R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>pm_14403_23_23816250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AB76743-499F-4EF7-85AD-8D88661C7076</gtr:id><gtr:title>Mapping the progression of progranulin-associated frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Nature clinical practice. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1745-834X</gtr:issn><gtr:outcomeId>fuuW9SSoNyU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78DB2A26-8C98-4B84-A810-41D5C2E650EB</gtr:id><gtr:title>FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab9e3dde384013eef79f476bf114e0e9"><gtr:id>ab9e3dde384013eef79f476bf114e0e9</gtr:id><gtr:otherNames>Urwin H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_14403_23_20490813</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A34CFCAC-2227-4467-89AE-80B9285727A3</gtr:id><gtr:title>Structural magnetic resonance imaging-derived biomarkers for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Biomarkers in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c3aed68c9625297800eab8ea5b4792"><gtr:id>69c3aed68c9625297800eab8ea5b4792</gtr:id><gtr:otherNames>Barnes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1752-0363</gtr:issn><gtr:outcomeId>pm_14403_23_20477462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E28C9295-4558-4594-A0E8-4CCC6E5444A1</gtr:id><gtr:title>Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d0bd8be8c0cc6e77fbf2c4529d24742"><gtr:id>4d0bd8be8c0cc6e77fbf2c4529d24742</gtr:id><gtr:otherNames>van de Pol LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5D45D3768D8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DF0D391-FCA3-4D8F-BD82-91BEE3113A39</gtr:id><gtr:title>Ten simple rules for reporting voxel-based morphometry studies.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cab53386592ee6a55a622a3691128c13"><gtr:id>cab53386592ee6a55a622a3691128c13</gtr:id><gtr:otherNames>Ridgway GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>2B4A28687FD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8312B304-BECD-40BA-B342-54DDC08B1047</gtr:id><gtr:title>Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis</gtr:title><gtr:parentPublicationTitle>The Lancet Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d271c4aa5ab11326832c2cffb80b7910"><gtr:id>d271c4aa5ab11326832c2cffb80b7910</gtr:id><gtr:otherNames>Tabrizi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>56df3e0be49054.94173296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C857A426-B829-41EC-B24D-0D82A6AF5B41</gtr:id><gtr:title>Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4f7c18861e0038910c2956da676a621"><gtr:id>d4f7c18861e0038910c2956da676a621</gtr:id><gtr:otherNames>Lehmann M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>d95uA5oEcBd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3024A07-CAD1-4D95-8323-A8D0B84F5F2E</gtr:id><gtr:title>Posterior cortical atrophy.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c1d422149b7bc9c3fe99eb09392b20b"><gtr:id>2c1d422149b7bc9c3fe99eb09392b20b</gtr:id><gtr:otherNames>Crutch SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_14403_23_22265212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF1B18D1-B873-47CE-87F9-5C0EF49E142D</gtr:id><gtr:title>Validation of next-generation sequencing technologies in genetic diagnosis of dementia.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_14403_23_23998997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FAE9170-FE8A-40CF-9428-1DEABBD8DA72</gtr:id><gtr:title>Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11c32b1aab0f3a5f1db049ca78168d33"><gtr:id>11c32b1aab0f3a5f1db049ca78168d33</gtr:id><gtr:otherNames>Henneman WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>C0AB41129DB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>629E78D4-1BD5-46F0-ABBF-C0CFC4773807</gtr:id><gtr:title>Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders.</gtr:title><gtr:parentPublicationTitle>Current Alzheimer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/690f6b8519a228110f58dfaad0a53be2"><gtr:id>690f6b8519a228110f58dfaad0a53be2</gtr:id><gtr:otherNames>Vellas B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1567-2050</gtr:issn><gtr:outcomeId>368A9D2CBB8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0B148B0-271A-4516-AD09-F037D8F29CF5</gtr:id><gtr:title>Functional connectivity in autosomal dominant and late-onset Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2295a11886f1b02ec603612b48e5b62"><gtr:id>b2295a11886f1b02ec603612b48e5b62</gtr:id><gtr:otherNames>Thomas JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>545ba2cee2d365.47697429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B268380B-F0D4-4AB1-9EFC-8FC54AA52241</gtr:id><gtr:title>A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66a813233bf3cf77d42e145cf9dd01de"><gtr:id>66a813233bf3cf77d42e145cf9dd01de</gtr:id><gtr:otherNames>Salloway S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>FFFE3B0F400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24853CAF-7E04-4C64-A455-29217059D518</gtr:id><gtr:title>The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33f6d1286765f98e3d1c0e7c6e23f4c5"><gtr:id>33f6d1286765f98e3d1c0e7c6e23f4c5</gtr:id><gtr:otherNames>Cash DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_14403_23_24049139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEEE930E-34E6-400E-ADA0-D9F82A80220C</gtr:id><gtr:title>STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation.</gtr:title><gtr:parentPublicationTitle>Medical image analysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/751fa2fcfb6b96c9d082b89879f7c9bf"><gtr:id>751fa2fcfb6b96c9d082b89879f7c9bf</gtr:id><gtr:otherNames>Jorge Cardoso M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1361-8415</gtr:issn><gtr:outcomeId>pm_14403_23_23510558</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>190A6F09-F699-4C1F-9CC6-E1C895B8DFBD</gtr:id><gtr:title>Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b2d14505f1916bc463c5643c1c28d8"><gtr:id>56b2d14505f1916bc463c5643c1c28d8</gtr:id><gtr:otherNames>Guerreiro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_14403_23_23649896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE6A5445-1438-4671-9AB3-A7C92E5857E0</gtr:id><gtr:title>Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease.</gtr:title><gtr:parentPublicationTitle>AJNR. American journal of neuroradiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/630640179f879075bcbfb4ea1de914e2"><gtr:id>630640179f879075bcbfb4ea1de914e2</gtr:id><gtr:otherNames>Henley SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0195-6108</gtr:issn><gtr:outcomeId>jGGM5fkXsGg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>757CE74C-5FF7-489E-89F3-8919443B1D12</gtr:id><gtr:title>Head size, age and gender adjustment in MRI studies: a necessary nuisance?</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c3aed68c9625297800eab8ea5b4792"><gtr:id>69c3aed68c9625297800eab8ea5b4792</gtr:id><gtr:otherNames>Barnes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>BzhqWCUWWcp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D90CFC6B-6F8D-4628-B726-3ACF4CC2F6FC</gtr:id><gtr:title>An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea06b4851ed697d3e3b5a0239fb864c2"><gtr:id>ea06b4851ed697d3e3b5a0239fb864c2</gtr:id><gtr:otherNames>Fonteijn HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_14403_23_22281676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0F55A86-F32F-46F4-AB8D-35A24695F5CC</gtr:id><gtr:title>Reduced cortical thickness in the posterior cingulate gyrus is characteristic of both typical and atypical Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4f7c18861e0038910c2956da676a621"><gtr:id>d4f7c18861e0038910c2956da676a621</gtr:id><gtr:otherNames>Lehmann M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>piXUiTaH3tr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47F6574B-FF5B-46A1-A5CA-0FBE26714B5E</gtr:id><gtr:title>Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>tchcbapjiQa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F7A40BB-52AB-44CC-B478-D913B450A2D9</gtr:id><gtr:title>Pure progressive amnesia and the APPV717G mutation.</gtr:title><gtr:parentPublicationTitle>Alzheimer disease and associated disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b121c4c0c64cd8e2e7e65f5c4be9911"><gtr:id>0b121c4c0c64cd8e2e7e65f5c4be9911</gtr:id><gtr:otherNames>Knight WD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0893-0341</gtr:issn><gtr:outcomeId>3E89AEF2FDB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFDFFDE4-0099-4995-A4D4-9491BF322A37</gtr:id><gtr:title>Memory complaints and increased rates of brain atrophy: risk factors for mild cognitive impairment and Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>International journal of geriatric psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47adce141336e8a72143ae842018daeb"><gtr:id>47adce141336e8a72143ae842018daeb</gtr:id><gtr:otherNames>Archer HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-6230</gtr:issn><gtr:outcomeId>pm-14403-20084620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76563B1B-8B29-47B6-BDC1-C08A5D5628D4</gtr:id><gtr:title>Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b121c4c0c64cd8e2e7e65f5c4be9911"><gtr:id>0b121c4c0c64cd8e2e7e65f5c4be9911</gtr:id><gtr:otherNames>Knight WD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56df3e0b786f46.67676004</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BAD73FB-721D-49DD-92AF-2E293910C35F</gtr:id><gtr:title>A peek behind the curtain: amyloid imaging, referrals, and specialist memory evaluations.</gtr:title><gtr:parentPublicationTitle>Alzheimer disease and associated disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f04e659a751dfc709721dbff0341902"><gtr:id>0f04e659a751dfc709721dbff0341902</gtr:id><gtr:otherNames>Foster NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0893-0341</gtr:issn><gtr:outcomeId>pm_14403_23_23411640</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A200009-588E-4071-B6DB-5E721F10C41C</gtr:id><gtr:title>The clinical profile of right temporal lobe atrophy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3571a59cf17a8b69aaf30bc0846d1ec"><gtr:id>b3571a59cf17a8b69aaf30bc0846d1ec</gtr:id><gtr:otherNames>Chan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>7E8D4DA7D44</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEF8BD2D-7B4F-4A42-B77A-15211F6F4040</gtr:id><gtr:title>Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07e74972561be40ab721f911617b3191"><gtr:id>07e74972561be40ab721f911617b3191</gtr:id><gtr:otherNames>Lambert JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_14403_23_24162737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5AFF2E7-30FC-4E29-B1B3-4226A61F9801</gtr:id><gtr:title>Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/611f202ad90c9900b8baf6c0f7a04781"><gtr:id>611f202ad90c9900b8baf6c0f7a04781</gtr:id><gtr:otherNames>Scahill RI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm_14403_23_23380992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E801820-BE2D-4008-AF84-F7B8BAC0A7DC</gtr:id><gtr:title>An event-based disease progression model and its application to familial Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Information processing in medical imaging : proceedings of the ... conference</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea06b4851ed697d3e3b5a0239fb864c2"><gtr:id>ea06b4851ed697d3e3b5a0239fb864c2</gtr:id><gtr:otherNames>Fonteijn HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1011-2499</gtr:issn><gtr:outcomeId>56df3e0c2f3315.61839491</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9224FF9F-1C23-451D-A995-555A6217FCCC</gtr:id><gtr:title>Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9310cf284c8313db35d3785d3e32077"><gtr:id>a9310cf284c8313db35d3785d3e32077</gtr:id><gtr:otherNames>Harold D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>91503C47332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BA4EDCE-B549-45A6-821F-5EF00F4D13E4</gtr:id><gtr:title>Molecular nexopathies: a new paradigm of neurodegenerative disease.</gtr:title><gtr:parentPublicationTitle>Trends in neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53d738fa9ba6d1c8484ec4f210b08967"><gtr:id>53d738fa9ba6d1c8484ec4f210b08967</gtr:id><gtr:otherNames>Warren JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0166-2236</gtr:issn><gtr:outcomeId>pm_14403_23_23876425</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0C71CC2-98DE-4682-83D9-6850F326C24A</gtr:id><gtr:title>Basic visual function and cortical thickness patterns in posterior cortical atrophy.</gtr:title><gtr:parentPublicationTitle>Cerebral cortex (New York, N.Y. : 1991)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4f7c18861e0038910c2956da676a621"><gtr:id>d4f7c18861e0038910c2956da676a621</gtr:id><gtr:otherNames>Lehmann M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1047-3211</gtr:issn><gtr:outcomeId>TfgNHG8iGKH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41CE55C7-C99E-4D21-B9A6-DEF1A04061E7</gtr:id><gtr:title>The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fadb846c4bf0f743bd514b4d59eb4741"><gtr:id>fadb846c4bf0f743bd514b4d59eb4741</gtr:id><gtr:otherNames>Massey LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_14403_23_23616165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF80367C-8FB7-4C60-A948-E4BA3A257AF1</gtr:id><gtr:title>Automated quantification of caudate atrophy by local registration of serial MRI: evaluation and application in Huntington's disease.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cb8a78e67b2350728fe64236392c6db"><gtr:id>5cb8a78e67b2350728fe64236392c6db</gtr:id><gtr:otherNames>Hobbs NZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>8A6B331F61A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30771A8A-B91D-42A9-8063-F8B0D5F2F2AC</gtr:id><gtr:title>Imaging biomarkers in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2f8dfe154301fda0ca7dc5fa167fe8"><gtr:id>9b2f8dfe154301fda0ca7dc5fa167fe8</gtr:id><gtr:otherNames>Ryan NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>2E346DF6707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35B0D5BD-D145-468C-B245-7D09ABAEB064</gtr:id><gtr:title>Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/318097b3d5edbae2eea3f080430dde67"><gtr:id>318097b3d5edbae2eea3f080430dde67</gtr:id><gtr:otherNames>Okello A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>7A82267D78F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12E13128-FF64-46CE-BFE3-D05C37F01E8E</gtr:id><gtr:title>A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c3aed68c9625297800eab8ea5b4792"><gtr:id>69c3aed68c9625297800eab8ea5b4792</gtr:id><gtr:otherNames>Barnes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>C406A605AA2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25E8B092-2952-4D90-9A04-95A2F0684E3F</gtr:id><gtr:title>Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4f7c18861e0038910c2956da676a621"><gtr:id>d4f7c18861e0038910c2956da676a621</gtr:id><gtr:otherNames>Lehmann M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>13D6AEE226C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E00FF04-1808-470E-BF0D-31DD1CFC660A</gtr:id><gtr:title>Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b5327600fac0a638eaadd910fc3aca7"><gtr:id>8b5327600fac0a638eaadd910fc3aca7</gtr:id><gtr:otherNames>Jack CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>56df3e0d1e6484.44459449</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>611470D7-7779-4567-A377-463DA790324B</gtr:id><gtr:title>Does registration of serial MRI improve diagnosis of dementia?</gtr:title><gtr:parentPublicationTitle>Neuroradiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c3aed68c9625297800eab8ea5b4792"><gtr:id>69c3aed68c9625297800eab8ea5b4792</gtr:id><gtr:otherNames>Barnes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3940</gtr:issn><gtr:outcomeId>rK9Tscv2wvX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F1A193A-E893-4752-9A6E-77149781EE16</gtr:id><gtr:title>Genetic variability in CLU and its association with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f54cad0ab0877e543fc660186cd44ff0"><gtr:id>f54cad0ab0877e543fc660186cd44ff0</gtr:id><gtr:otherNames>Guerreiro RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>ZnSFXmJxyQB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>716B76A7-738F-47BC-AC41-622F67E2C78F</gtr:id><gtr:title>Endpoints for trials in Alzheimer's disease: a European task force consensus.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/690f6b8519a228110f58dfaad0a53be2"><gtr:id>690f6b8519a228110f58dfaad0a53be2</gtr:id><gtr:otherNames>Vellas B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_14403_13_18420157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B9818A9-ED22-4DB1-8D77-DF0DBE3F3B03</gtr:id><gtr:title>Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ac40b969c64db850e438e12bb3e323"><gtr:id>59ac40b969c64db850e438e12bb3e323</gtr:id><gtr:otherNames>Jones L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>DdCvbphZz9P</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2441D95A-E52E-4323-9807-EFF555617E31</gtr:id><gtr:title>Brain MAPS: an automated, accurate and robust brain extraction technique using a template library.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40e53561e2b3385a34842c6ebd022b3b"><gtr:id>40e53561e2b3385a34842c6ebd022b3b</gtr:id><gtr:otherNames>Leung KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>56df3e0b95cfe1.32023546</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3A18CF5-9F28-4FBD-A692-0ADCAC1EB54C</gtr:id><gtr:title>Early-onset Alzheimer disease clinical variants: multivariate analyses of cortical thickness.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cab53386592ee6a55a622a3691128c13"><gtr:id>cab53386592ee6a55a622a3691128c13</gtr:id><gtr:otherNames>Ridgway GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_14403_23_22722624</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F60BE51-7D10-4DDD-A85C-CF6F50A872FB</gtr:id><gtr:title>Quantitative magnetization transfer imaging in Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8a50fff89e7a652804bc999010bc265"><gtr:id>d8a50fff89e7a652804bc999010bc265</gtr:id><gtr:otherNames>Ridha BH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0033-8419</gtr:issn><gtr:outcomeId>26A73F3DF36</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9075B87-F473-4E97-A8F2-1E81848F5D3A</gtr:id><gtr:title>Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e7a2aaff095ddfd459f6f62ef8b765c"><gtr:id>3e7a2aaff095ddfd459f6f62ef8b765c</gtr:id><gtr:otherNames>Evans MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>198516195C1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9399C317-4386-480B-ADE2-3770D59AF022</gtr:id><gtr:title>Progressive logopenic/phonological aphasia: erosion of the language network.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pjmF4M4JanA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F1F6293-C94F-4A7E-BF99-26432EDB7980</gtr:id><gtr:title>The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b5327600fac0a638eaadd910fc3aca7"><gtr:id>8b5327600fac0a638eaadd910fc3aca7</gtr:id><gtr:otherNames>Jack CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn><gtr:outcomeId>DC817F3696D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C81A0B3B-6353-49E8-8CCC-A9A7DEAE71AD</gtr:id><gtr:title>Word-finding difficulty: a clinical analysis of the progressive aphasias.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>171246B7B00</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8206D0F1-721A-43D7-8481-45570E4E181A</gtr:id><gtr:title>Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b5327600fac0a638eaadd910fc3aca7"><gtr:id>8b5327600fac0a638eaadd910fc3aca7</gtr:id><gtr:otherNames>Jack CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>WexVU2E2Ca8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>319946C9-57D6-4009-AE85-104343309EC5</gtr:id><gtr:title>Microglial activation and amyloid deposition in mild cognitive impairment: a PET study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/318097b3d5edbae2eea3f080430dde67"><gtr:id>318097b3d5edbae2eea3f080430dde67</gtr:id><gtr:otherNames>Okello A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>0BC2475BACC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>954106DB-2267-4B1C-98A8-C8D8587123C6</gtr:id><gtr:title>An alternative method for estimating efficacy of the AN1792 vaccine for Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffa868d36c3f569bb100c604ad793610"><gtr:id>ffa868d36c3f569bb100c604ad793610</gtr:id><gtr:otherNames>Grundman M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>1ED6B8F5496</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95B43237-3916-45CB-A4BC-C1B8E403CD18</gtr:id><gtr:title>Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b7bc67e86a896d8699dccda7511ae9"><gtr:id>28b7bc67e86a896d8699dccda7511ae9</gtr:id><gtr:otherNames>Andrews KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14403_23_23554933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>825451BB-93F6-4D8A-8049-33DCDE301004</gtr:id><gtr:title>Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions.</gtr:title><gtr:parentPublicationTitle>Alzheimer's research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/028989dcafa83dba91c03e918dc57a1d"><gtr:id>028989dcafa83dba91c03e918dc57a1d</gtr:id><gtr:otherNames>Mahoney CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>pm_14403_23_23006986</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>256D9A04-B922-47C0-969E-06B9CCD197A1</gtr:id><gtr:title>Structural neuroanatomy of tinnitus and hyperacusis in semantic dementia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/028989dcafa83dba91c03e918dc57a1d"><gtr:id>028989dcafa83dba91c03e918dc57a1d</gtr:id><gtr:otherNames>Mahoney CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56df3e0a59e940.99052387</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE8F006A-B77C-49B9-ADB6-5F92CD0E5D7B</gtr:id><gtr:title>Impact of apolipoprotein E4-cerebrospinal fluid ?-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ca5aefd85bc2b5f68827a98d7d30df9"><gtr:id>3ca5aefd85bc2b5f68827a98d7d30df9</gtr:id><gtr:otherNames>Chiang GC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>nY7e6mttgd1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30584412-D7D4-473E-8751-9F3D7EF471FF</gtr:id><gtr:title>Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11c32b1aab0f3a5f1db049ca78168d33"><gtr:id>11c32b1aab0f3a5f1db049ca78168d33</gtr:id><gtr:otherNames>Henneman WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>D0879E59839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA08088D-6925-4490-A580-4CE9DDC63F38</gtr:id><gtr:title>Longitudinal imaging in dementia.</gtr:title><gtr:parentPublicationTitle>The British journal of radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/611f202ad90c9900b8baf6c0f7a04781"><gtr:id>611f202ad90c9900b8baf6c0f7a04781</gtr:id><gtr:otherNames>Scahill RI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0007-1285</gtr:issn><gtr:outcomeId>19C1F45F660</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77226C14-B2A0-45BD-9FAD-F1DE31B9617D</gtr:id><gtr:title>Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdd7216ab40c1b77b1f4628587ba13e1"><gtr:id>cdd7216ab40c1b77b1f4628587ba13e1</gtr:id><gtr:otherNames>Benzinger TL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14403_23_24194552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C618775-B390-427F-8A7E-A62765350F12</gtr:id><gtr:title>Presymptomatic generalized brain atrophy in frontotemporal dementia caused by CHMP2B mutation.</gtr:title><gtr:parentPublicationTitle>Dementia and geriatric cognitive disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1420-8008</gtr:issn><gtr:outcomeId>593148CAE1F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19470A9E-2054-444D-AE06-ABFACB571C15</gtr:id><gtr:title>Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f05d5c8816acacbd274481d87778e2e"><gtr:id>5f05d5c8816acacbd274481d87778e2e</gtr:id><gtr:otherNames>Edison P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>D269883584D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4299BC5-ABB9-4A28-AA3C-0C6CB025630E</gtr:id><gtr:title>Magnetic resonance imaging predictors of cognition in mild cognitive impairment.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d0bd8be8c0cc6e77fbf2c4529d24742"><gtr:id>4d0bd8be8c0cc6e77fbf2c4529d24742</gtr:id><gtr:otherNames>van de Pol LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>28D91135948</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>057C9A5E-2064-4E6F-863E-078BA8817EE0</gtr:id><gtr:title>EFNS task force: the use of neuroimaging in the diagnosis of dementia.</gtr:title><gtr:parentPublicationTitle>European journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2deb3bad43536c8c939526c0265dbb29"><gtr:id>2deb3bad43536c8c939526c0265dbb29</gtr:id><gtr:otherNames>Filippi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1351-5101</gtr:issn><gtr:outcomeId>pm_14403_23_22900895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E25D2B1D-B052-4A53-9994-7E31D0ADBC3B</gtr:id><gtr:title>Motor features in posterior cortical atrophy and their imaging correlates.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2f8dfe154301fda0ca7dc5fa167fe8"><gtr:id>9b2f8dfe154301fda0ca7dc5fa167fe8</gtr:id><gtr:otherNames>Ryan NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>545ba2cf43f264.99371172</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>280C521E-066D-4A05-8488-338152217A05</gtr:id><gtr:title>Identification of an important potential confound in CSF AD studies: aliquot volume.</gtr:title><gtr:parentPublicationTitle>Clinical chemistry and laboratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a896c05ff079b09bbd8b7d45f25746b3"><gtr:id>a896c05ff079b09bbd8b7d45f25746b3</gtr:id><gtr:otherNames>Toombs J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1434-6621</gtr:issn><gtr:outcomeId>pm_14403_23_23940064</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8F18289-6376-4FF7-9769-CBF95ECE7E64</gtr:id><gtr:title>Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61702583ef39986bd78a7590de9f6e32"><gtr:id>61702583ef39986bd78a7590de9f6e32</gtr:id><gtr:otherNames>Sluimer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>DC4FD7008F1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B72419C9-E172-4D50-9102-8910E58C03B7</gtr:id><gtr:title>Automated measurement of hippocampal atrophy using fluid-registered serial MRI in AD and controls.</gtr:title><gtr:parentPublicationTitle>Journal of computer assisted tomography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c3aed68c9625297800eab8ea5b4792"><gtr:id>69c3aed68c9625297800eab8ea5b4792</gtr:id><gtr:otherNames>Barnes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0363-8715</gtr:issn><gtr:outcomeId>927B2ED0415</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31C464E8-14FB-4AD8-89C1-D32179B16CD6</gtr:id><gtr:title>An unbiased longitudinal analysis framework for tracking white matter changes using diffusion tensor imaging with application to Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4e9b7a48f8efc2532bfcacdd0998128"><gtr:id>a4e9b7a48f8efc2532bfcacdd0998128</gtr:id><gtr:otherNames>Keihaninejad S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_14403_23_23370057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0C60D35-B3AA-4156-88CF-525BA95D05E4</gtr:id><gtr:title>Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/630640179f879075bcbfb4ea1de914e2"><gtr:id>630640179f879075bcbfb4ea1de914e2</gtr:id><gtr:otherNames>Henley SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>A8C119CCEEE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70A56564-DE07-49E7-9A16-7670A6642334</gtr:id><gtr:title>Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56df3e0b50ebe8.71336800</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F201CB27-0E9A-4D95-ABEE-BA3A025E4E60</gtr:id><gtr:title>Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal Alzheimer's disease images.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a202feb84b5ac6d19d90ffb3ca2ecced"><gtr:id>a202feb84b5ac6d19d90ffb3ca2ecced</gtr:id><gtr:otherNames>Camara O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>8BB673F9196</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA4EF031-595C-48F3-82E5-A04B72C1401F</gtr:id><gtr:title>White matter tract signatures of the progressive aphasias.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/028989dcafa83dba91c03e918dc57a1d"><gtr:id>028989dcafa83dba91c03e918dc57a1d</gtr:id><gtr:otherNames>Mahoney CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_14403_23_23312804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC8F501B-39F3-4E86-BAB4-CB0423536F38</gtr:id><gtr:title>Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/705a00e6deb957c9dcb44602557a49a0"><gtr:id>705a00e6deb957c9dcb44602557a49a0</gtr:id><gtr:otherNames>Wilkinson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm_14403_23_22269160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4878566A-205A-4E04-88F1-CAC1D761FC8E</gtr:id><gtr:title>Alzheimer disease: Visual rating of atrophy aids diagnostic accuracy.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2f8dfe154301fda0ca7dc5fa167fe8"><gtr:id>9b2f8dfe154301fda0ca7dc5fa167fe8</gtr:id><gtr:otherNames>Ryan NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>7C65814D389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98E5E2BD-719D-47DA-AC2A-FEF598D902D9</gtr:id><gtr:title>Serial volumetric MRI in Parkinsonian disorders.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2ad55e1a2ad1526b8ced1a4945eda9d"><gtr:id>c2ad55e1a2ad1526b8ced1a4945eda9d</gtr:id><gtr:otherNames>Wild EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>6786AE51A74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FCBFD41-BB74-4760-A445-41855D92F53C</gtr:id><gtr:title>Increasing power to predict mild cognitive impairment conversion to Alzheimer's disease using hippocampal atrophy rate and statistical shape models.</gtr:title><gtr:parentPublicationTitle>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40e53561e2b3385a34842c6ebd022b3b"><gtr:id>40e53561e2b3385a34842c6ebd022b3b</gtr:id><gtr:otherNames>Leung KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>rfLb6kU2ebB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C91BDD6E-157F-49FA-BE3F-E4164860B7E7</gtr:id><gtr:title>Memory complaints and increased rates of brain atrophy: risk factors for mild cognitive impairment and Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>International journal of geriatric psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47adce141336e8a72143ae842018daeb"><gtr:id>47adce141336e8a72143ae842018daeb</gtr:id><gtr:otherNames>Archer HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-6230</gtr:issn><gtr:outcomeId>ACbhYF6ywmL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA3F5241-AD65-499A-AE10-9C79E76AA6C0</gtr:id><gtr:title>An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64c5cb13cfda226b9b9221708cf27f87"><gtr:id>64c5cb13cfda226b9b9221708cf27f87</gtr:id><gtr:otherNames>Petzold A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>5F9D1C6834E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AD3A0A9-A8B3-4DFC-954E-25DBA8516BB7</gtr:id><gtr:title>Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal data.</gtr:title><gtr:parentPublicationTitle>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a202feb84b5ac6d19d90ffb3ca2ecced"><gtr:id>a202feb84b5ac6d19d90ffb3ca2ecced</gtr:id><gtr:otherNames>Camara O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>86A93BD9B83</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD599506-8115-480C-BD9D-A4928C0B5F6A</gtr:id><gtr:title>3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc352690755ae724b0f0d88d8e5b8ccf"><gtr:id>bc352690755ae724b0f0d88d8e5b8ccf</gtr:id><gtr:otherNames>Hua X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>AB3AE051D6C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5BF49FE-0522-4487-817B-46D8BADD4891</gtr:id><gtr:title>11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83ea0ba59f1e2da7b45663f0f74f969b"><gtr:id>83ea0ba59f1e2da7b45663f0f74f969b</gtr:id><gtr:otherNames>Rinne JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>Kk2QAetPy6L</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>721F0E56-6B81-4F1C-A2F1-2A3B9D91F9D3</gtr:id><gtr:title>Cerebral microbleeds in familial Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2f8dfe154301fda0ca7dc5fa167fe8"><gtr:id>9b2f8dfe154301fda0ca7dc5fa167fe8</gtr:id><gtr:otherNames>Ryan NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>M5bMwMcbrsi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A4DF0FF-D5B5-4D2F-AA85-1122D234AAB9</gtr:id><gtr:title>Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8a50fff89e7a652804bc999010bc265"><gtr:id>d8a50fff89e7a652804bc999010bc265</gtr:id><gtr:otherNames>Ridha BH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>BA34102EB7E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>909DAB2C-DECB-4CAB-9532-3CE345734BC4</gtr:id><gtr:title>LoAd: a locally adaptive cortical segmentation algorithm.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf214a08f70dd705690d3294a5e05052"><gtr:id>bf214a08f70dd705690d3294a5e05052</gtr:id><gtr:otherNames>Cardoso MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_14403_23_21316470</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64CCFCD5-4CE9-459C-9052-C350130B7A8F</gtr:id><gtr:title>Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1f713ca85ca27e13a0ae8556515b0c8"><gtr:id>e1f713ca85ca27e13a0ae8556515b0c8</gtr:id><gtr:otherNames>Rascovsky K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56df3e0a764f92.30869170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA5FEC5D-2474-4DD6-8A36-7F9FE1C649FE</gtr:id><gtr:title>Acceleration of cortical thinning in familial Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b121c4c0c64cd8e2e7e65f5c4be9911"><gtr:id>0b121c4c0c64cd8e2e7e65f5c4be9911</gtr:id><gtr:otherNames>Knight WD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>4A3BEEE888B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B9225C1-436F-4B09-A0FA-212D57663491</gtr:id><gtr:title>The heritability and genetics of frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>72E5C3E9E3D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2798C16F-66C4-4FA6-90D8-6013987AA4BD</gtr:id><gtr:title>Impaired default network functional connectivity in autosomal dominant Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53426fcad9396e8882844ebfc8f5c893"><gtr:id>53426fcad9396e8882844ebfc8f5c893</gtr:id><gtr:otherNames>Chhatwal JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_14403_23_23884042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9212DE10-7DAD-4C45-AF4B-4D5F9B0F22AD</gtr:id><gtr:title>Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/665fb8e90c07e18553ccf791cbf9a1cb"><gtr:id>665fb8e90c07e18553ccf791cbf9a1cb</gtr:id><gtr:otherNames>Smith SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>8163198FB98</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA727DCD-E7FE-498C-9EC0-2E7DE89A799B</gtr:id><gtr:title>Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ?4 allele</gtr:title><gtr:parentPublicationTitle>The Lancet Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/376dcfb7e31d9ba32cc8a583b8ba2e81"><gtr:id>376dcfb7e31d9ba32cc8a583b8ba2e81</gtr:id><gtr:otherNames>van der Flier W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>56df3e0ab737a9.58709661</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00227F73-C47E-41B1-8483-C66BA2804F9E</gtr:id><gtr:title>Fast free-form deformation using graphics processing units.</gtr:title><gtr:parentPublicationTitle>Computer methods and programs in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53fd3c1ac8bc5b92fd5802dfffd57b79"><gtr:id>53fd3c1ac8bc5b92fd5802dfffd57b79</gtr:id><gtr:otherNames>Modat M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0169-2607</gtr:issn><gtr:outcomeId>43216EA8B2E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FEB4584-9ABB-4DB7-BE48-0E13FE2B8C23</gtr:id><gtr:title>Suspected early dementia.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a9c2586c68901d5c8cc3129e94e33d"><gtr:id>29a9c2586c68901d5c8cc3129e94e33d</gtr:id><gtr:otherNames>Schott JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>pm_14403_23_21933826</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67906FAC-0116-4466-BD99-8400F35568B0</gtr:id><gtr:title>Imaging cadavers: cold FLAIR and noninvasive brain thermometry using CSF diffusion.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fabb1e5e190e3698d72ac9bf86d6a2ef"><gtr:id>fabb1e5e190e3698d72ac9bf86d6a2ef</gtr:id><gtr:otherNames>Tofts PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>B9377EE17BC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>295E22A8-CA85-444C-8E22-DF2337B7875E</gtr:id><gtr:title>Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38c85904b1c9eb5fa28ea95b05adb438"><gtr:id>38c85904b1c9eb5fa28ea95b05adb438</gtr:id><gtr:otherNames>Mormino EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>2AE058F5374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08DFF133-2EDC-4F61-909B-42EB327E82AD</gtr:id><gtr:title>Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d8bb83004a4e25d25f13d660f65b4a3"><gtr:id>8d8bb83004a4e25d25f13d660f65b4a3</gtr:id><gtr:otherNames>Seelaar H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56df3e0b2c4bf8.47124016</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>569D8634-9115-44A3-AE20-93EB5637DA94</gtr:id><gtr:title>The diagnosis of young-onset dementia.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6920f09eaa7cc6860a9b3ff0ad7df175"><gtr:id>6920f09eaa7cc6860a9b3ff0ad7df175</gtr:id><gtr:otherNames>Rossor MN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>56df3e0ded3431.51607520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B26C612-ACB8-4899-A6FE-C1AD1C129AB4</gtr:id><gtr:title>The clinical and neuroanatomical phenotype of FUS associated frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56df3e0a1d0069.61526896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CEC58AF-6226-45B7-A5D6-A459A575A524</gtr:id><gtr:title>A cognitive chameleon: lessons from a novel MAPT mutation case.</gtr:title><gtr:parentPublicationTitle>Neurocase</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96925e58fc50223a95dd6d10f9850bc0"><gtr:id>96925e58fc50223a95dd6d10f9850bc0</gtr:id><gtr:otherNames>Liang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1355-4794</gtr:issn><gtr:outcomeId>pm_14403_23_23998300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4DFA3E6-E254-484E-B441-12AB618A3DA6</gtr:id><gtr:title>Algorithms, atrophy and Alzheimer's disease: cautionary tales for clinical trials.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83020163299cc994d00571299cd55717"><gtr:id>83020163299cc994d00571299cd55717</gtr:id><gtr:otherNames>Fox NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>56df3e0c887848.90712894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33962546-FDC7-4060-9A53-76F87E2D4B67</gtr:id><gtr:title>Visual assessment of posterior atrophy development of a MRI rating scale.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b1517c740fceb580a1e17b781645da6"><gtr:id>9b1517c740fceb580a1e17b781645da6</gtr:id><gtr:otherNames>Koedam EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>BjzfPWTej3e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B9BFD59-0E67-45D1-98A7-2A9046A42983</gtr:id><gtr:title>Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40e53561e2b3385a34842c6ebd022b3b"><gtr:id>40e53561e2b3385a34842c6ebd022b3b</gtr:id><gtr:otherNames>Leung KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>56df3e0e38f0d6.08094414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>296DAF54-7EA3-45C6-9F29-2F05F5233252</gtr:id><gtr:title>The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5f57c58edf8f995fb15d901ac0c6948"><gtr:id>d5f57c58edf8f995fb15d901ac0c6948</gtr:id><gtr:otherNames>Albert MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>56df3e09e99725.01184454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7791E4A-B41E-435D-9A2B-1DAA62270B62</gtr:id><gtr:title>Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study.</gtr:title><gtr:parentPublicationTitle>AJNR. American journal of neuroradiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cb8a78e67b2350728fe64236392c6db"><gtr:id>5cb8a78e67b2350728fe64236392c6db</gtr:id><gtr:otherNames>Hobbs NZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0195-6108</gtr:issn><gtr:outcomeId>cRN8cMkhoZx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4E45B31-A300-4391-9448-AFB3EEF1B2A0</gtr:id><gtr:title>Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients.</gtr:title><gtr:parentPublicationTitle>Radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61702583ef39986bd78a7590de9f6e32"><gtr:id>61702583ef39986bd78a7590de9f6e32</gtr:id><gtr:otherNames>Sluimer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0033-8419</gtr:issn><gtr:outcomeId>8F21BD4F90F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>552FE456-6975-441B-B0EF-AE59147CCA33</gtr:id><gtr:title>Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c3aed68c9625297800eab8ea5b4792"><gtr:id>69c3aed68c9625297800eab8ea5b4792</gtr:id><gtr:otherNames>Barnes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_14403_23_23522844</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF86B0BA-E50B-40DD-B455-6779808CBEDD</gtr:id><gtr:title>Reply: Implications of presymptomatic change in thalamus and caudate in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2f8dfe154301fda0ca7dc5fa167fe8"><gtr:id>9b2f8dfe154301fda0ca7dc5fa167fe8</gtr:id><gtr:otherNames>Ryan NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_14403_23_23824491</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C09E939A-5653-47ED-A868-173D3CDCC4FC</gtr:id><gtr:title>Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eeebeaa623a1644c5fee34b914c47435"><gtr:id>eeebeaa623a1644c5fee34b914c47435</gtr:id><gtr:otherNames>Sperling R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_14403_23_22305802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3061DA0-713E-4453-8F8F-F166C46CDA51</gtr:id><gtr:title>Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4f7c18861e0038910c2956da676a621"><gtr:id>d4f7c18861e0038910c2956da676a621</gtr:id><gtr:otherNames>Lehmann M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_14403_23_22516280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93051C83-C3D8-4399-BA0C-1ECCF7A80787</gtr:id><gtr:title>Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba4315959f583752dd1a062546606127"><gtr:id>ba4315959f583752dd1a062546606127</gtr:id><gtr:otherNames>Gordon E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>MBmyip7fQGG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91231008-CDB4-4E52-9402-D44826C6E25A</gtr:id><gtr:title>A Novel MAPT Mutation Causing Corticobasal Syndrome Led by Progressive Apraxia of Speech.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ea1feb377e0b3a562dd1f424ed51ab7"><gtr:id>6ea1feb377e0b3a562dd1f424ed51ab7</gtr:id><gtr:otherNames>Marshall CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>5648c9c3343cf6.82490364</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2137AE8B-F654-411B-A8E5-49459573BFA5</gtr:id><gtr:title>The clinical use of structural MRI in Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0693a531bd90c9e2d3a868ffc53529f2"><gtr:id>0693a531bd90c9e2d3a868ffc53529f2</gtr:id><gtr:otherNames>Frisoni GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>F6iGtbb4XFR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2C424C3-0894-4E23-9489-B8DC4CDB8B2D</gtr:id><gtr:title>Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a9c2586c68901d5c8cc3129e94e33d"><gtr:id>29a9c2586c68901d5c8cc3129e94e33d</gtr:id><gtr:otherNames>Schott JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>g448LtD8GKr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>168EC2F0-031F-4778-800F-B02DA4B6949F</gtr:id><gtr:title>Defective emotion recognition in early HD is neuropsychologically and anatomically generic.</gtr:title><gtr:parentPublicationTitle>Neuropsychologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/630640179f879075bcbfb4ea1de914e2"><gtr:id>630640179f879075bcbfb4ea1de914e2</gtr:id><gtr:otherNames>Henley SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3932</gtr:issn><gtr:outcomeId>B6367BBF0BE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DF9EDAB-197E-483A-9F3F-21516A646896</gtr:id><gtr:title>No evidence that extended tracts of homozygosity are associated with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9da89c318f56fc7256d9d74b60d23229"><gtr:id>9da89c318f56fc7256d9d74b60d23229</gtr:id><gtr:otherNames>Sims R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>q4ykgeevDhK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35A0027B-9497-48A3-BD1C-D78482E37560</gtr:id><gtr:title>Tracking progression in frontotemporal lobar degeneration: serial MRI in semantic dementia.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>PypVsv7Mzw7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A02578D7-2DE4-43D3-853A-52E46D508CFC</gtr:id><gtr:title>Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47054bfb42d1d50e9b926c45969ff093"><gtr:id>47054bfb42d1d50e9b926c45969ff093</gtr:id><gtr:otherNames>Boyes RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>B3D0F82C2A0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D65CFB18-3997-4F39-B7E3-0D2E6E193307</gtr:id><gtr:title>Clinical and biomarker changes in dominantly inherited Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b563b78623bb94ca0d20ecd88c28c37"><gtr:id>0b563b78623bb94ca0d20ecd88c28c37</gtr:id><gtr:otherNames>Bateman RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_14403_23_22784036</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41F739B0-0501-4946-B232-684C8D2A7A21</gtr:id><gtr:title>The role of variation at A?PP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/719950cfe57960088e8c4cb5aaf09b14"><gtr:id>719950cfe57960088e8c4cb5aaf09b14</gtr:id><gtr:otherNames>Gerrish A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm_14403_23_22027014</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FD7DE96-3D34-4F87-81E0-64EFE4513112</gtr:id><gtr:title>Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/630640179f879075bcbfb4ea1de914e2"><gtr:id>630640179f879075bcbfb4ea1de914e2</gtr:id><gtr:otherNames>Henley SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>C6BD6A9A9F6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F746B3CA-ABE4-443B-9DC3-F8B53879B57E</gtr:id><gtr:title>Visualizing the emergence of posterior cortical atrophy.</gtr:title><gtr:parentPublicationTitle>Neurocase</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b55984ac4981c4129599754497376cb"><gtr:id>5b55984ac4981c4129599754497376cb</gtr:id><gtr:otherNames>Kennedy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1355-4794</gtr:issn><gtr:outcomeId>pm_14403_23_22026812</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>742E1441-CAE8-4D21-A070-3AC350DD2D65</gtr:id><gtr:title>Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>AJNR. American journal of neuroradiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47b2886b67bf83ab34decc4f1f1ad6bf"><gtr:id>47b2886b67bf83ab34decc4f1f1ad6bf</gtr:id><gtr:otherNames>Karas G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0195-6108</gtr:issn><gtr:outcomeId>pm_14403_13_18296551</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601846</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>